|Articles|April 14, 2021
- Pharmaceutical Executive-04-01-2021
- Volume 41
- Issue 4
Pharmaceutical Executive, April 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive April 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 5 years ago
SPACs: From Fad to Fixture: COVID Sparks Greater Use of IPO Alternativealmost 5 years ago
The Challenges of Worker Qualification Management in Pharmaalmost 5 years ago
The Future of Telehealth: Evolving COVID Perspectives Offer Cluesalmost 5 years ago
Years in the Making: A Repeat Recognition—Uninterruptedalmost 5 years ago
Pharm Exec at 40 (1990-1993)almost 5 years ago
The Power of Parityalmost 5 years ago
No Limits to Science, Or Selfalmost 5 years ago
In Silico in Sight as Biopharma Game-Changeralmost 5 years ago
Long-View Innovation Hopes for Pharma Policy in the EUNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5

